SCHEMBL8709388

SCHEMBL8709388

O=C(NCC1(Cc2ccccc2)CCNCC1)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
OPRM1 P35372 1/20 0.43
FKBP1A P62942 1/20 0.43
NPFFR1 Q9GZQ6 5/20 0.43
NPFFR2 Q9Y5X5 5/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
OPRK1 P41145 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8708223 0.85 NPFFR1 (0.60) HTTOPRM1NPFFR1NPFFR2OPRK1
SCHEMBL8710585 0.77 SMYD3 (0.54) HTTCYP2C9CYP2C19FKBP1AMEN1
SCHEMBL8393626 0.74 USP2 (0.64) HTTCYP2C9CYP2C19FKBP1AMEN1
SCHEMBL6643951 0.73 SLC6A2 (0.42) NPFFR1NPFFR2CYP2D6OPRK1
SCHEMBL10253586 0.72 HPGD (0.48) HTTNPFFR1NPFFR2OPRK1MEN1
SCHEMBL4631300 0.72 ALDH1A1 (0.58) HTTCYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL28218804 0.72 MEN1 (0.74) CYP2C9CYP2C19FKBP1AMEN1KMT2A
SCHEMBL10254764 0.71 P2RX7 (0.50) MEN1KMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL7498000 0.70 TSHR (0.49) CYP2C9CYP2C19OPRM1CYP2D6MEN1
SCHEMBL17117357 0.70 NAMPT (0.66) HTTCYP2C9CYP2C19FKBP1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998018762-A1 NEW DERIVATIVES OF DIVERSELY SUBSTITUTED CYCLICAL AMIDE SELECTIVE ANTAGONISTS OF THE HUMAN RECEPTOR NK3, PROCESS FOR OBTAINING THEM, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI (FR) 1998-05-07 WO disclosed